NewAmsterdam Pharma Co. NV (NAMS)
20.60
+0.10
(+0.49%)
USD |
NASDAQ |
Oct 28, 12:02
NewAmsterdam Pharma Market Cap : 2.424B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 2.412B |
| October 26, 2026 | 2.298B |
| October 23, 2026 | 2.319B |
| October 22, 2026 | 2.539B |
| October 21, 2026 | 2.528B |
| October 20, 2026 | 2.530B |
| October 19, 2026 | 2.408B |
| October 16, 2026 | 2.333B |
| October 15, 2026 | 2.426B |
| October 14, 2026 | 2.354B |
| October 13, 2026 | 2.375B |
| October 12, 2026 | 2.500B |
| October 09, 2026 | 2.538B |
| October 08, 2026 | 2.501B |
| October 07, 2026 | 2.604B |
| October 06, 2026 | 2.620B |
| October 05, 2026 | 2.682B |
| October 02, 2026 | 2.730B |
| October 01, 2026 | 2.842B |
| September 30, 2026 | 2.861B |
| September 29, 2026 | 2.801B |
| September 28, 2026 | 2.774B |
| September 25, 2026 | 2.657B |
| September 24, 2026 | 2.675B |
| September 23, 2026 | 2.668B |
| Date | Value |
|---|---|
| September 22, 2026 | 2.744B |
| September 21, 2026 | 2.657B |
| September 18, 2026 | 2.646B |
| September 17, 2026 | 2.580B |
| September 16, 2026 | 2.492B |
| September 15, 2026 | 2.490B |
| September 14, 2026 | 2.631B |
| September 11, 2026 | 2.682B |
| September 10, 2026 | 2.572B |
| September 09, 2026 | 2.681B |
| September 08, 2026 | 3.015B |
| September 04, 2026 | 2.988B |
| September 03, 2026 | 3.041B |
| September 02, 2026 | 3.011B |
| September 01, 2026 | 2.932B |
| August 31, 2026 | 2.981B |
| August 28, 2026 | 3.047B |
| August 27, 2026 | 3.152B |
| August 26, 2026 | 3.224B |
| August 25, 2026 | 3.217B |
| August 24, 2026 | 3.159B |
| August 21, 2026 | 3.279B |
| August 20, 2026 | 3.268B |
| August 19, 2026 | 3.357B |
| August 18, 2026 | 3.206B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 186.99M |
| Pharming Group NV | 863.49M |
| argenx SE | 55.21B |
| Alnylam Pharmaceuticals, Inc. | 30.12B |
| Ionis Pharmaceuticals, Inc. | 7.281B |
Market Cap Related Metrics
| PS Ratio | 346.05 |
| PEG Ratio | -0.2698 |
| Price to Book Value | 3.838 |
| Price | 20.60 |
| Earnings Yield | -10.57% |
| PEGY Ratio | -0.2698 |